The presentation of the international information and humanitarian campaign in support of Ukraine, "Ukraine: Defending Freedom," was held in London, the Superhumans Center reported on Facebook. The presentation was initiated by the Superhumans Center and featured British entrepreneur Richard Branson and world boxing champion Oleksandr Usyk.
The campaign's key visual symbol is a modified statue of Florence Nightingale, located in Westminster. The traditional lamp in her hands has been replaced with a modern bionic prosthesis in the colors of the Ukrainian flag, as a "reminder to the world of the price Ukraine pays for freedom." Ukraine: Defending Freedom aims not only to inform the international community but also to strengthen support for Ukrainian veterans and wounded civilians.
The campaign tells the stories of Ukrainian and foreign soldiers and volunteers who lost limbs during the war but who have not lost their dignity and strength to live. Among the heroes are Eddie, a British volunteer who received prosthetics from Superhumans after being wounded in Ukraine, and Ruslana, a 22-year-old Ukrainian Armed Forces veteran who not only recovered from the loss of her leg but also joined the center's team as a staff member. The campaign features five individuals whose stories have become part of a global message of invincibility. Details can be found on the initiative's official website .
" For Ukraine, this is another voice, another platform that speaks of our pain and strength to the entire planet. For the world, this is a reminder that freedom has a price. And today, Ukraine is paying it ," writes the Superhumans Center.
Recently, an international team of neuroscientists presented a new approach to reducing the body's rejection of prostheses. The scientists developed neuroperipheral implants embedded with dexamethasone molecules, an anti-inflammatory drug that inhibits the immune response and allows electrodes to "embed" into the nervous system without scarring. The scientists believe this discovery could significantly reduce the risk of neuroprosthetic rejection in the future. Following clinical testing, the development is expected to have practical application in military and civilian rehabilitation.
Noticed a mistake?
Please select it with your mouse and press Ctrl+Enter or Submit an error